Juul, the American electronic cigarette company, was previously banned from selling its products by the U.S. Food and Drug Administration (USFDA) due to public health-related issues. However, more than two weeks after the announcement, the federal agency lifted the ban order, but this is only temporary.
As per Reuters, the FDA suspended the ban while it starts a new review on Juul's case. The additional review was put in place as the e-cigarette company filed an appeal for the regulator's decision to ban Juul's products from the market.
With the ban being lifted, the company will be able to sell its products once again while the appeal is being reviewed. It was on June 23 when Juul Labs Inc. was ordered to pull out its e-cigarettes from the market. The company is partly owned by the Altria Group Inc. tobacco giant.
In its appeal to the U.S. federal appeals court, the company said that the ban will cause irreparable harm to its business. Thus it was granted a temporary permit to sell but based on the court's scheduling order, this will only be in effect until July 12.
In explaining its decision to allow Juul to continue selling, the FDA posted a series of tweets and one stated, "The agency has determined that there are scientific issues unique to the Juul application that warrant additional review."
The federal health agency also clarified that while the ban has been lifted while the additional review is being carried out, this does not mean that its initial order has been revoked.
Meanwhile, Fox Business reported that the company failed to provide enough evidence that shows keeping its products on the market "would be appropriate for the protection of the public health."
Now, since the ban was only suspended until next week, Juul must prove that adult smokers who use its e-cigarettes are likely to cut down or quit smoking altogether. It should also prove that teenagers are not likely to become addicted to using electronic cigarettes. The company must prove these points to the FDA so it can stay on the market.
"Today's action is further progress on the FDA's commitment to ensuring that all e-cigarette and electronic nicotine delivery system products currently being marketed to consumers meet our public health standards," Robert Califf, FDA's commissioner, said when the agency banned Juul last month.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Australia’s December Trade Surplus Expands but Falls Short of Expectations
India Services Sector Rebounds in January as New Business Gains Momentum: HSBC PMI Shows Growth
U.S. Stock Futures Edge Higher as Tech Rout Deepens on AI Concerns and Earnings 



